8-K - SAB Biotherapeutics, Inc. (0001833214) (Filer)
Published . Updated .
Filed: 2026-10-13 AccNo: 0001193125-26-419769 Size: 244 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- SABS SAB Biotherapeutics
Named in this report.
- SABSW SAB BIOTHERAPEUTICS INC
SEC 8-K filing -> direct issuer disclosure -> SABSW
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-13 AccNo: 0001193125-26-419769 Size: 244 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
SAB Biotherapeutics (SABSW) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.14% | final price |
| GLD | the next day | -1.62% | final price |
| GLD | two days later | +0.13% | final price |
| GLD | three days later | -0.03% | final price |
| GLD | three days earlier | -0.93% | final price |
| GLD | five days earlier | +0.03% | final price |
| QQQ | that day | -0.32% | final price |
| QQQ | the next day | -2.28% | final price |
| QQQ | two days later | -2.39% | final price |
| QQQ | three days later | -4.85% | final price |
| QQQ | three days earlier | +0.20% | final price |
| QQQ | five days earlier | +1.83% | final price |
| SAB Biotherapeutics (SABSW) | that day | 0.00% | final price |
| SAB Biotherapeutics (SABSW) | the next day | 0.00% | final price |
| SAB Biotherapeutics (SABSW) | two days later | 0.00% | final price |
| SAB Biotherapeutics (SABSW) | three days later | 0.00% | final price |
| SAB Biotherapeutics (SABSW) | three days earlier | 0.00% | final price |
| SAB Biotherapeutics (SABSW) | five days earlier | 0.00% | final price |
| SPY | that day | 0.00% | final price |
| SPY | the next day | -1.08% | final price |
| SPY | two days later | -0.80% | final price |
| SPY | three days later | -1.89% | final price |
| SPY | three days earlier | -0.53% | final price |
| SPY | five days earlier | +0.14% | final price |
| TLT | that day | +0.42% | final price |
| TLT | the next day | +1.10% | final price |
| TLT | two days later | +2.52% | final price |
| TLT | three days later | +2.58% | final price |
| TLT | three days earlier | -0.21% | final price |
| TLT | five days earlier | -0.97% | final price |
Who is named in “8-K - SAB Biotherapeutics, Inc. (0001833214) (Filer)”
Companies tied to this story
- SABSW SAB Biotherapeutics
In “8-K - SAB Biotherapeutics, Inc. (0001833214) (Filer),” SAB Biotherapeutics (SABSW) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> SABSW
How “8-K - SAB Biotherapeutics, Inc. (0001833214) (Filer)” reaches SAB Biotherapeutics (SABSW)
SAB Biotherapeutics (SABSW) is the company in “8-K - SAB Biotherapeutics, Inc. (0001833214) (Filer),” the 13 Oct 2026 this story story.
The link for SAB Biotherapeutics (SABSW) is this: SEC 8-K filing -> direct issuer disclosure -> SABSW
A simple score for SAB Biotherapeutics (SABSW)
19 out of 100
“8-K - SAB Biotherapeutics, Inc. (0001833214) (Filer)” scores 19 out of 100. The score uses 1 sources, a +1.08% difference versus the S&P 500 (SPY), and 1 linked companies.